BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/11/2023 8:05:04 AM | Browse: 368 | Download: 1106
 |
Received |
|
2022-12-30 23:17 |
 |
Peer-Review Started |
|
2022-12-30 23:19 |
 |
First Decision by Editorial Office Director |
|
2023-01-22 06:08 |
 |
Return for Revision |
|
2023-01-22 06:08 |
 |
Revised |
|
2023-02-14 23:54 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2023-04-04 03:27 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2023-04-04 08:37 |
 |
Articles in Press |
|
2023-04-04 08:37 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-05-05 06:39 |
 |
Publish the Manuscript Online |
|
2023-05-11 08:05 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Anatomy & Morphology |
| Manuscript Type |
Review |
| Article Title |
Study of tumor necrosis factor receptor in the inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Roberta Figueiroa Souza, Marcos Antônio Ferreira Caetano, Henrique Inhauser Riceti Magalhães and Patricia Castelucci |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Research Support Foundation of the State of São Paulo, Brazil |
2014/25927-2 |
| Research Support Foundation of the State of São Paulo, Brazil |
2018/07862-1 |
| National Council for Scientific and Technological Development (CNPq, Brazil) |
|
| Higher Education Personnel Improvement Coordination (CAPES, Brazil) |
|
|
| Corresponding Author |
Patricia Castelucci, MHSc, PhD, Associate Professor, Associate Research Scientist, Lecturer, Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, Av. Dr. Lineu Prestes, 2415, São Paulo 05508-000, Brazil. pcastel@usp.br |
| Key Words |
Tumor necrosis factor 1 receptor; Tumor necrosis factor 2 receptor; Inflammatory bowel diseases; Enteric nervous system; tumor necrosis factor-alpha |
| Core Tip |
This review summarizes the role of Tumor Necrosis Factor-alpha (TNF-α) in promoting inflammation. Studies have suggested that TNF-α is one of the main pro-inflammatory cytokines involved in the pathogenesis of IBD. In addition, the enteric nervous system is affected by IBD. There are two receptors for TNF: the tumor necrosis factor 1 receptor; and the tumor necrosis factor 2 receptor. They are involved in the pathogenesis of IBD. The application of antibodies aimed at neutralizing TNF-α in patients with IBD induce a satisfactory clinical recovery. This review addresses the main aspects of TNF-α in IBD and anti-TNF therapies. |
| Publish Date |
2023-05-11 08:05 |
| Citation |
Souza RF, Caetano MAF, Magalhães HIR, Castelucci P. Study of tumor necrosis factor receptor in the inflammatory bowel disease. World J Gastroenterol 2023; 29(18): 2733-2746 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i18/2733.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i18.2733 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.